IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.169
EU - Europa 2.921
AS - Asia 1.815
SA - Sud America 321
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.125
IE - Irlanda 1.120
HK - Hong Kong 693
IT - Italia 693
SG - Singapore 622
GB - Regno Unito 332
BR - Brasile 284
CN - Cina 252
DE - Germania 232
UA - Ucraina 160
GR - Grecia 82
FR - Francia 67
KR - Corea 59
FI - Finlandia 49
TR - Turchia 47
SE - Svezia 36
IN - India 29
CA - Canada 26
NL - Olanda 23
RO - Romania 23
BE - Belgio 20
PK - Pakistan 16
CZ - Repubblica Ceca 15
EG - Egitto 15
RU - Federazione Russa 15
IR - Iran 14
MX - Messico 13
ID - Indonesia 11
AT - Austria 10
AR - Argentina 8
LT - Lituania 8
TW - Taiwan 8
AZ - Azerbaigian 7
CO - Colombia 7
PE - Perù 7
ES - Italia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
UZ - Uzbekistan 5
BD - Bangladesh 4
CH - Svizzera 4
IL - Israele 4
JO - Giordania 4
JP - Giappone 4
PL - Polonia 4
PT - Portogallo 4
VE - Venezuela 4
ZA - Sudafrica 4
DK - Danimarca 3
EU - Europa 3
KG - Kirghizistan 3
MA - Marocco 3
MK - Macedonia 3
PH - Filippine 3
VN - Vietnam 3
AM - Armenia 2
BO - Bolivia 2
CL - Cile 2
CY - Cipro 2
GE - Georgia 2
HU - Ungheria 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
OM - Oman 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
UG - Uganda 2
AL - Albania 1
AN - Antille olandesi 1
BW - Botswana 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 8.257
Salva come PNG Salva come JPEG
Città #
Dublin 1.106
Hong Kong 693
Santa Clara 597
Chandler 404
Jacksonville 287
Singapore 192
Princeton 155
Roxbury 150
New York 146
The Dalles 135
Naples 120
Bremen 100
Cambridge 85
Caserta 83
Medford 72
Ann Arbor 58
Seoul 58
Beijing 50
Wilmington 49
Des Moines 47
Falkenstein 34
Ashburn 30
Boardman 30
Napoli 29
São Paulo 27
Nanjing 26
Redwood City 25
Woodbridge 25
Milan 21
Brussels 20
Washington 20
Munich 19
Mountain View 18
Los Angeles 17
Atlanta 15
Helsinki 15
Jinan 15
Aversa 14
London 14
Shenyang 14
Houston 12
Amsterdam 11
Giugliano In Campania 11
Norwalk 11
Monserrato 10
Rio de Janeiro 9
San Mateo 9
Taizhou 9
Timisoara 9
Chicago 8
Istanbul 8
Lahore 8
Lappeenranta 8
Marano Di Napoli 8
Nuremberg 8
Shanghai 8
Curitiba 7
Florence 7
Guastalla 7
Haikou 7
Liveri 7
Paris 7
Stuttgart 7
Toronto 7
Zanjan 7
Baku 6
Brno 6
Changsha 6
Damietta 6
Hangzhou 6
Hebei 6
Lanzhou 6
Perugia 6
Porto Alegre 6
Sacramento 6
Taipei 6
Tianjin 6
Zhengzhou 6
Brasília 5
Chennai 5
Duncan 5
Fairfield 5
Frankfurt am Main 5
La Prairie 5
Moscow 5
Mumbai 5
Nanchang 5
Ottawa 5
Philadelphia 5
Rome 5
Salvador 5
Samsun 5
Seattle 5
Vienna 5
Amman 4
Athens 4
Auburn Hills 4
Belo Horizonte 4
Groningen 4
Guangzhou 4
Totale 5.407
Salva come PNG Salva come JPEG
Nome #
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 112
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 102
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 100
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 100
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 99
Bartter syndrome 98
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 85
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 83
A genic and epigenetic combination therapy for liver cancer 83
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 83
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 78
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 78
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 77
Sonoporation by microbubbles as gene therapy approach against liver cancer 74
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 74
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 72
Chronic HCV infection and neurological and psychiatric disorders: an overview. 71
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 69
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 69
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 69
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 68
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 68
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 68
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 67
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 67
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 65
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 65
Chronic HCV infection is a risk factor of ischemic stroke 64
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 62
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 62
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 62
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 62
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 62
What changed in the Italian internal medicine and geriatric wards during the lockdown 62
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 61
Spirometry in elderly laryngectomized patients: A feasibility study 61
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 61
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 61
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 61
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 60
[Next Generation Sequencing and ADPKD] 60
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 60
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 59
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 59
HCV-related steatosis and risk of atherosclerosis 59
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 59
Chronic Hepatitis C Virus Infection and Depression. 58
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 58
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 57
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 56
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 56
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 56
HCC and molecular targeting therapies: Back to the future 56
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 56
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 56
Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment. Predictive Factors and Role of Epigenetics 55
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 55
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 54
Seasonal variations of hyponatremia in the emergency department: Age-related changes 54
Cardiovascular benefits from gliflozins: Effects on endothelial function 54
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 53
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 53
Association between the spread of COVID-19 and weather-climatic parameters 53
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 53
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 52
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 52
Renal handling of uric acid 51
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 51
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 49
SARS-CoV-2 vaccine development: Where are we? 49
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 49
Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients 48
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 48
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 48
Non-alcoholic fatty liver disease beyond the liver is an emerging multifaceted systemic disease 47
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 47
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 47
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 46
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 46
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 46
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 46
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 46
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 45
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 45
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 45
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 44
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience 44
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis. 44
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis. 44
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 44
Antioxidant diet and genotyping as tools for the prevention of liver disease 44
Atypical presentation of a rare parasitic infection with fasciola hepatica: A multidisciplinary case report 44
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 44
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 44
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 44
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 43
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress 43
TISSUE RESONANCE INTERACTION METHOD: A CHALLENGE FOR THE EARLY AND NON-INVASIVE DIAGNOSIS OF SOLID CANCERS 43
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: Incidence, characteristics, risk factors and survival 43
High HDL Cholesterol: a risk factor for Diabetic Retinopathy? Findings from NO BLIND study 43
Totale 5.952
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 0 0 0 0 0 0 0 0 0 0 49 21
2020/2021619 24 24 39 29 110 35 147 42 14 37 89 29
2021/2022983 25 4 16 27 299 20 15 23 71 75 86 322
2022/20231.966 181 62 56 87 241 123 6 99 1.006 21 37 47
2023/20241.128 84 30 56 67 312 173 36 38 22 40 92 178
2024/20252.859 29 66 18 61 532 404 491 313 522 412 11 0
Totale 8.713